Celldex Therapeutics (CLDX) Interest Coverage Ratio Growth (5y) (2015 - 2025)

Celldex Therapeutics (CLDX) Interest Coverage Ratio Growth (5y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Celldex Therapeutics 1.72 Mn 1.72 Mn -1.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1,107.02%
Dec 31, 2024 -15.21%
Sep 30, 2024 -197.10%
Jun 30, 2024 -4.28%
Mar 31, 2024 -4.24%
Dec 31, 2023 -27.11%
Dec 31, 2022 1.57%
Dec 31, 2020 6.95%
Dec 31, 2019 111.18%
Dec 31, 2018 76.71%
Dec 31, 2017 71.01%
Dec 31, 2015 -14.89%